Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Daniel R Premkumar, Esther P Jane & Ian F Pollack. (2015) Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells. Cancer Biology & Therapy 16:2, pages 233-243.
Read now
Read now
Yong-Song Guan, Qing He & Mei Li. (2014)
Icotinib: activity and clinical application in Chinese patients with lung cancer. Expert Opinion on Pharmacotherapy 15:5, pages 717-728.
Read now
Read now
Koji Yoshimoto, Masahiro Mizoguchi, Nobuhiro Hata, Toshiyuki Amano, Akira Nakamizo & Tomio Sasaki. (2012) Molecular biomarkers of glioblastoma: current targets and clinical implications. Current Biomarker Findings 2, pages 63-76.
Read now
Read now
Articles from other publishers (25)
Nameeta Shah, Pavan M. Hallur, Raksha A. Ganesh, Pranali Sonpatki, Divya Naik, Komal Prasad Chandrachari, Ralph B. Puchalski & Aditya Chaubey. (2021) Gelatin methacrylate hydrogels culture model for glioblastoma cells enriches for mesenchymal-like state and models interactions with immune cells. Scientific Reports 11:1.
Crossref
Crossref
Raul Bardini Bressan & Steven M. Pollard. 2020. Stem Cell Epigenetics. Stem Cell Epigenetics
231
255
.
Joseph Scafidi, Jonathan Ritter, Brooke M. Talbot, Jorge Edwards, Li-Jin Chew & Vittorio Gallo. (2018) Age-Dependent Cellular and Behavioral Deficits Induced by Molecularly Targeted Drugs Are Reversible. Cancer Research 78:8, pages 2081-2095.
Crossref
Crossref
Daniel R. Premkumar, Esther P. Jane, Swetha Thambireddy, Philip A. Sutera, Jonathon M. Cavaleri & Ian F. Pollack. (2018) Mitochondrial dysfunction RAD51, and Ku80 proteolysis promote apoptotic effects of Dinaciclib in Bcl-xL silenced cells. Molecular Carcinogenesis 57:4, pages 469-482.
Crossref
Crossref
S. Pedron, H. Polishetty, A. M. Pritchard, B. P. Mahadik, Carl R. Woese, J. N. Sarkaria & B. A. C. Harley. (2017) Spatially graded hydrogels for preclinical testing of glioblastoma anticancer therapeutics. MRS Communications 7:3, pages 442-449.
Crossref
Crossref
Esther P. Jane, Daniel R. Premkumar, Philip A. Sutera, Jonathon M. Cavaleri & Ian F. Pollack. (2017) Survivin inhibitor YM155 induces mitochondrial dysfunction, autophagy, DNA damage and apoptosis in Bcl-xL silenced glioma cell lines. Molecular Carcinogenesis 56:4, pages 1251-1265.
Crossref
Crossref
Ronghua Tang, Chen Liang, Jian Shangguan & Shiwen Guo. (2017) The Effects of All-Trans Retinoic Acid on Vasculogenic Mimicry Formation Ability in CD133+ Glioma Stem Cells and Its Mechanisms. Journal of Biosciences and Medicines 05:04, pages 42-54.
Crossref
Crossref
Philip J. O’Halloran, Thomas Viel, David W. Murray, Lydia Wachsmuth, Katrin Schwegmann, Stefan Wagner, Klaus Kopka, Monika A. Jarzabek, Patrick Dicker, Sven Hermann, Cornelius Faber, Tim Klasen, Michael Schäfers, David O’Brien, Jochen H. M. Prehn, Andreas H. Jacobs & Annette T. Byrne. (2016) Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers. European Journal of Nuclear Medicine and Molecular Imaging 43:9, pages 1673-1683.
Crossref
Crossref
Merryl R. Lobo, Ayaka Kukino, Huong Tran, Matthias C. Schabel, Charles S. Springer, G. Yancey Gillespie, Marjorie R. Grafe, Randall L. Woltjer & Martin M. Pike. (2015) Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma. PLOS ONE 10:12, pages e0144488.
Crossref
Crossref
Elisabetta Rovida & Barbara Stecca. (2015) Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?. Seminars in Cancer Biology 35, pages 154-167.
Crossref
Crossref
Shiao-Pei Weathers, Barbara J. O'Brien, John F. de Groot & W. K. Alfred Yung. 2015. Targeted Therapy in Translational Cancer Research. Targeted Therapy in Translational Cancer Research
177
189
.
Merryl R. Lobo, Xiaoyan Wang, G. Yancey Gillespie, Randall L. Woltjer & Martin M. Pike. (2014) Combined Efficacy of Cediranib and Quinacrine in Glioma Is Enhanced by Hypoxia and Causally Linked to Autophagic Vacuole Accumulation. PLoS ONE 9:12, pages e114110.
Crossref
Crossref
Lotte M.E. Berghauser Pont, Jochem K.H. Spoor, Subramanian Venkatesan, Sigrid Swagemakers, Jenneke J. Kloezeman, Clemens M.F. Dirven, Peter J. van der Spek, Martine L.M. Lamfers & Sieger Leenstra. (2014) The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells. Genes & Cancer 5:11-12, pages 445-459.
Crossref
Crossref
Vidyalakshmi Chandramohan, Xuhui Bao, Mika Kato Kaneko, Yukinari Kato, Stephen T. Keir, Scott E. Szafranski, Chien‐Tsun Kuan, Ira H. Pastan & Darell D. Bigner. (2012) Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors. International Journal of Cancer 132:10, pages 2339-2348.
Crossref
Crossref
Ainoha García-Claver, Mar Lorente, Pilar Mur, Yolanda Campos-Martín, Manuela Mollejo, Guillermo Velasco & Bárbara Meléndez. (2013) Gene expression changes associated with erlotinib response in glioma cell lines. European Journal of Cancer 49:7, pages 1641-1653.
Crossref
Crossref
HUANJIANG NIU, KUN WANG, ANLING ZHANG, SHUXU YANG, ZHENGFEI SONG, WEI WANG, CONG QIAN, XINWEI LI, YINXIN ZHU & YIRONG WANG. (2012) miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. Oncology Reports 28:5, pages 1771-1777.
Crossref
Crossref
Bin Xu, Wen‐yan Zheng, Da‐yong Jin, Dan‐song Wang, Xin‐yuan Liu & Xin‐yu Qin. (2012) Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin‐2 gene. Cancer 118:21, pages 5217-5226.
Crossref
Crossref
Benjamin A. Hoff, Mahaveer S. Bhojani, John Rudge, Thomas L. Chenevert, Charles R. Meyer, Stefanie Galbán, Timothy D. Johnson, Judith Sebolt Leopold, Alnawaz Rehemtulla, Brian D. Ross & Craig J. Galbán. (2012) DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model. NMR in Biomedicine 25:7, pages 935-942.
Crossref
Crossref
Soudeh Ghafouri-FardMohammad-Hossein Modarressi. (2012) Expression of cancer–testis genes in brain tumors: implications for cancer immunotherapy. Immunotherapy 4:1, pages 59-75.
Crossref
Crossref
Yan Cheng, Yi Zhang, Li Zhang, Xingcong Ren, Kathryn J. Huber-Keener, Xiaoyuan Liu, Lei Zhou, Jason Liao, Heike Keihack, Li Yan, Eric Rubin & Jin-Ming Yang. (2012) MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis. Molecular Cancer Therapeutics 11:1, pages 154-164.
Crossref
Crossref
Cuixian Li, Chun Zhou, Shaogui Wang, Ying Feng, Wei Lin, Sisi Lin, Ying Wang, Heqing Huang, Peiqing Liu, Yong-Gao Mu & Xiaoyan Shen. (2011) Sensitization of Glioma Cells to Tamoxifen-Induced Apoptosis by Pl3-Kinase Inhibitor through the GSK-3β/β-Catenin Signaling Pathway. PLoS ONE 6:10, pages e27053.
Crossref
Crossref
A. B. Gaur, S. L. Holbeck, N. H. Colburn & M. A. Israel. (2011) Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro-Oncology 13:6, pages 580-590.
Crossref
Crossref
Rajarshi Sengupta, Tao Sun, Nicole M. Warrington & Joshua B. Rubin. (2011) Treating brain tumors with PDE4 inhibitors. Trends in Pharmacological Sciences 32:6, pages 337-344.
Crossref
Crossref
Peng Cao, Xueting Cai, Wuguang Lu, Fei Zhou & Jiege Huo. (2011) Growth Inhibition and Induction of Apoptosis in SHG-44 Glioma Cells by Chinese Medicine Formula “Pingliu Keli”. Evidence-Based Complementary and Alternative Medicine 2011, pages 1-9.
Crossref
Crossref
Ian F. Pollack, Ronald L. Hamilton, Peter C. Burger, Daniel J. Brat, Marc K. Rosenblum, Geoffrey H. Murdoch, Marina N. Nikiforova, Emiko J. Holmes, Tianni Zhou, Kenneth J. Cohen & Regina I. Jakacki. (2010) Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children’s Oncology Group. Journal of Neuro-Oncology 99:2, pages 155-163.
Crossref
Crossref